Chitin and chitosan-based bioink for 3D-printed flexible electronics have tremendous potential for innovation in healthcare, agriculture, the environment, and industry. This biomaterial is suitable for 3D printing because it is highly stretchable, super-flexible, affordable, ultrathin, and lightweight. Owing to its ease of use, on-demand manufacturing, accurate and regulated deposition, and versatility with flexible and soft functional materials, 3D printing has revolutionized free-form construction and end-user customization. This study examined the potential of employing chitin and chitosan-based bioinks to build 3D-printed flexible electronic devices and optimize bioink formulation, printing parameters, and postprocessing processes to improve mechanical and electrical properties. The exploration of 3D-printed chitin and chitosan-based flexible bioelectronics will open new avenues for new flexible materials for numerous industrial applications.

A direct comparison of the impact of RF coil design under specific absorption rate andB1+rmslimitations are investigated and quantified using RF coils of different geometries and topologies at 64 MHz and 128 MHz. The RF-inducedin vivoelectric field and power deposition of a 50 cm long pacemaker and 55 cm long deep brain stimulator (DBS) are evaluated within two anatomical models exposed with these RF coils. The associated uncertainty is quantified and analyzed under a fixedB1+rmsincident and normal operating mode. For a fixedB1+rmsincident, thein vivoincident field shows a much higher uncertainty (>5.6 dB) to the RF coil diameter compared to other design parameters (e.g. <2.2 dB for coil length and topology), while the associated uncertainty reduced greatly (e.g. <1.5 dB) under normal operating mode exposure. Similar uncertainties are observed in the power deposition near the pacemaker and DBS electrode. Compared to the normal operating mode, applying a fixedB1+rmsfield to the untested implant will lead to a large variation in the induced incident and power deposition of the implant, as a result, a larger safe margin when different coil designs (e.g. coil diameter) are considered.

With the rising demand for implantable orthopaedic medical devices and the dominance of device-associated infections, extensive research into the development of novel materials has been prompted. Among these, new-generation titanium alloys with biocompatible elements and improved stiffness levels have received much attention. Furthermore, the development of titanium-based materials that can impart antibacterial function has demonstrated promising results, where gallium has exhibited superior antimicrobial action. This has been evidenced by the addition of gallium to various biomaterials including titanium alloys. Therefore, this paper aims to review the antibacterial activity of gallium when incorporated into biomedical materials, with a focus on titanium-based alloys. First, discussion into the development of new-generation Ti alloys that possess biocompatible elements and reduced Young\'s moduli is presented. This includes a brief review of the influence of alloying elements, processing techniques and the resulting biocompatibilities of the materials found in the literature. The antibacterial effect of gallium added to various materials, including bioglasses, liquid metals, and bioceramics, is then reviewed and discussed. Finally, a key focus is given to the incorporation of gallium into titanium systems for which the inherent mechanical, biocompatible, and antibacterial effects are reviewed and discussed in more detail, leading to suggestions and directions for further research in this area.

Poly (methyl methacrylate) (PMMA) is a synthetic polymer commonly used for medical implants in cranioplasty and orthopedic surgery owing to its excellent mechanical properties, optical transparency, and minimal inflammatory responses. Recently, the development of 3D printing opens new avenues in the fabrication of patient-specific PMMA implants for personalized medicine. However, challenges are confronted when adapting medical-grade PMMA to the 3D printing process due to its dynamic viscosity and nonself-supporting characteristics before cured. In addition, the intrinsically exothermic polymerization of MMA brings about bubble generation issues that reduce its mechanical performance harshly. Therefore, in this study, an embedded 3D printing methodology followed by pressurized thermo-curing is proposed and developed: a granular alginate microgel is designed for serving as a supporting matrix when jamming formed between the granules to structurally support the extruded precursor filaments of PMMA-MMA ink during both 3D printing and post-curing; moreover, the autoclave reactor enclosing the alginate matrix and as-sculpted PMMA structures is utilized to generate temperature-dependent pressure, which serves for suppressing the bubbles and solidifying the polymerized MMA during the post-curing process. The 3D printed PMMA is comparably matchable to traditional PMMA castings in terms of their microstructures, density, thermal properties, mechanical performance and biocompatibility. In the future, the proposed embedded 3D printing platform combined with the special post-curing method has great potential for a customized and cost-effective fabrication of patient-specific, complex and functional PMMA implants.

Objective.The objective of this work is to propose a machine learning-based approach to rapidly and efficiently model the radiofrequency (RF) transfer function of active implantable medical (AIM) electrodes, and to overcome the limitations and drawbacks of traditional measurement methods when applied to heterogeneous tissue environments.Approach.AIM electrodes with different geometries and proximate tissue distributions were considered, and their RF transfer functions were modeled numerically. Machine learning algorithms were developed and trained with the simulated transfer function datasets for homogeneous and heterogeneous tissue distributions. The performance of the method was analyzed statistically and validated experimentally and numerically. A comprehensive uncertainty analysis was performed and uncertainty budgets were derived.Main results.The proposed method is able to predict the RF transfer function of AIM electrodes under different tissue distributions, with mean correlation coefficientsrof 0.99 and 0.98 for homogeneous and heterogeneous environments, respectively. The results were successfully validated by experimental measurements (e.g. the uncertainty of less than 0.9 dB) and numerical simulation (e.g. transfer function uncertainty <1.6 dB and power deposition uncertainty <1.9 dB). Up to 1.3 dBin vivopower deposition underestimation was observed near generic pacemakers when using a simplified homogeneous tissue model.Significance.Provide an efficient alternative of transfer function modeling, which allows a more realistic tissue distribution and the potential underestimation ofin vivoRF-induced power deposition near the AIM electrode can be reduced.

Biomedical implants have recently shown excellent application potential in tissue repair and replacement. Applying three-dimensional (3D) printing to implant scaffold fabrication can help to address individual needs more precisely. Fourdimensional (4D) printing emerges rapidly based on the development of shape-responsive materials and design methods, which makes the production of dynamic functional implants possible. Smart implants can be pre-designed to respond to endogenous or exogenous stimuli and perform seamless integration with regular/ irregular tissue defects, defect-luminal organs, or curved structures via programmed shape morphing. At the same time, they offer great advantages in minimally invasive surgery due to the small-to-large volume transition. In addition, 4D-printed cellular scaffolds can generate extracellular matrix (ECM)-mimetic structures that interact with the contacting cells, expanding the possible sources of tissue/organ grafts and substitutes. This review summarizes the typical technologies and materials of 4D-printed scaffolds, and the programming designs and applications of these scaffolds are further highlighted. Finally, we propose the prospects and outlook of 4D-printed shape-morphing implants.

The widespread occurrence of bacterial infections and their increased resistance to antibiotics has led to the development of antimicrobial coatings for multiple medical implants. Owing to their desirable properties, gold nanoparticles (AuNPs) have been developed as antibacterial agents. This systematic investigation sought to analyze the antibacterial effects of implant material surfaces modified with AuNPs. The data from 27 relevant studies were summed up. The included articles were collected from September 2011 to September 2021. According to the retrieved literature, we found that medical implants modified by AuNPs have good antibacterial effects against gram-positive and gram-negative bacteria, and the antibacterial effects would be improved by near-infrared (NIR) radiation.

Carbon fibers reinforced polymers (CFRPs) are prolifically finding applications in the medical field, moving beyond the aerospace and automotive industries. Owing to its high strength-to-weight ratio, lightness and radiolucency, CFRP-based materials are emerging to replace traditional metal-based medical implants. Numerous types of polymers matrices can be incorporated with carbon fiber using various manufacturing methods, creating composites with distinct properties. Thus, prior to biomedical application, comprehensive evaluation of material properties, biocompatibility and safety are of paramount importance. In this study, we systematically evaluated a series of novel CFRPs, aiming at analyzing biocompatibility for future development into medical implants or implantable drug delivery systems. These CFRPs were produced either via Carbon Fiber-Sheet Molding Compound or Fused Deposition Modelling-based additive manufacturing. Unlike conventional methods, both fabrication processes afford high production rates in a time-and cost-effective manner. Importantly, they offer rapid prototyping and customization in view of personalized medical devices. Here, we investigate the physicochemical and surface properties, material mutagenicity or cytotoxicity of 20 CFRPs, inclusive of 2 surface finishes, as well as acute and sub-chronic toxicity in mice and rabbits, respectively. We demonstrate that despite moderate in vitro physicochemical and surface changes over time, most of the CFRPs were non-mutagenic and non-cytotoxic, as well as biocompatible in small animal models. Future work will entail extensive material assessment in the context of orthopedic applications such as evaluating potential for osseointegration, and a chronic toxicity study in a larger animal model, pigs.

It has been demonstrated that Ag-TiO2 nanocomposite coatings with excellent antimicrobial activity and biocompatibility have the potential to reduce infection problems. However, the mechanism of the synergistic effect of Ag-TiO2 coatings on antibacterial efficiency is still not well understood. In this study, five types of Ag-TiO2 nanocomposited coatings with different TiO2 contents were prepared on a titanium substratum. Leaching tests indicated that the incorporation of TiO2 nanoparticles into an Ag matrix significantly promoted Ag ion release. Surface energy measurements showed that the addition of TiO2 nanoparticles also significantly increased the electron donor surface energy of the coatings. Bacterial adhesion assays with Escherichia coli and Staphylococcus aureus demonstrated that the number of adhered bacteria decreased with increasing electron donor surface energy. The increased Ag ion release rate and the increased electron donor surface energy contributed to an enhanced antibacterial efficiency of the coatings.

Operation time of implantable electronic devices is largely constrained by the lifetime of batteries, which have to be replaced periodically by surgical procedures once exhausted, causing physical and mental suffering to patients and increasing healthcare costs. Besides the efficient scavenging of the mechanical energy of internal organs, this study proposes a self-powered, flexible, and one-stop implantable triboelectric active sensor (iTEAS) that can provide continuous monitoring of multiple physiological and pathological signs. As demonstrated in human-scale animals, the device can monitor heart rates, reaching an accuracy of ∼99%. Cardiac arrhythmias such as atrial fibrillation and ventricular premature contraction can be detected in real-time. Furthermore, a novel method of monitoring respiratory rates and phases is established by analyzing variations of the output peaks of the iTEAS. Blood pressure can be independently estimated and the velocity of blood flow calculated with the aid of a separate arterial pressure catheter. With the core-shell packaging strategy, monitoring functionality remains excellent during 72 h after closure of the chest. The in vivo biocompatibility of the device is examined after 2 weeks of implantation, proving suitability for practical use. As a multifunctional biomedical monitor that is exempt from needing an external power supply, the proposed iTEAS holds great potential in the future of the healthcare industry.